Efficacy and immune mechanisms of omega-3 as synergist in treatment of major depressive disorder

Functional foods and immunomodulatory in intervention of major depressive disorder

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPC-15006700

Enrollment

Unknown

Registered

2015-07-06

Start date

2015-07-20

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major depressive disorder

Interventions

A:Antidepressants + Omega-3

B:Antidepressants

Eligibility

Sex/Gender

Female

Age

No minimum to 45 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosed as major depressive disorder according to DSM-IV; 2. Score of Hamilton ratin scale for depression (17-items) >=18; 3. Duration of illness <2 years; 4. Age <=45 years old; 5. The race is Han and is female.

Exclusion criteria

Exclusion criteria: 1. Bipolar depression, or depression associated with physical illness or caused by substance abuse or dependence; 2. Previously drugs used or psychoactive substance dependence, or other mental disorders; 3. Nervous system diseases; 4. Obvious physical diseases; 5. In pregnant or lactating; 6. Needed treatment of MECT.

Design outcomes

Primary

Measure	Time frame
Hamilton ratin scale for depression (17-items);	—

Countries

China

Contacts

Public ContactLiping Cao

coolliping@163.com+86 20 81123695

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026